Literature DB >> 27052349

Evidence for a critical role of the sympathetic nervous system in hypertension.

Guido Grassi1, Venkata S Ram2.   

Abstract

Autonomic cardiovascular control is impaired in hypertension, leading to a reduction in the parasympathetic tone and to an increase in the sympathetic influences to the heart and peripheral vessels. The sympathetic dysfunction depends on a variety of reflex and nonreflex mechanisms and participates at development and progression of the essential hypertensive state. This has been shown to be the case for borderline hypertension, for moderate and severe high blood pressure, and for resistant hypertension as well. In addition, the adrenergic overdrive participates at the pathophysiology of the complex cardiometabolic alterations, known as "end-organ damage," detectable in the clinical course of hypertensive disease. In the present article, we will review the main features of the adrenergic abnormalities characterizing essential hypertension, the mechanisms potentially involved in this neural abnormality, and its consequences as well. We will also discuss the most recent information achieved in the field and the areas worthy of future investigations.
Copyright © 2016 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular risk; genetics; hypertension; sympathetic activity; target organ damage

Mesh:

Substances:

Year:  2016        PMID: 27052349     DOI: 10.1016/j.jash.2016.02.015

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  59 in total

1.  TRPV1 (Transient Receptor Potential Vanilloid 1) Cardiac Spinal Afferents Contribute to Hypertension in Spontaneous Hypertensive Rat.

Authors:  Julia Shanks; Sharon D B de Morais; Lie Gao; Irving H Zucker; Han-Jun Wang
Journal:  Hypertension       Date:  2019-08-19       Impact factor: 10.190

2.  Angiotensin Type 1 Receptors and Superoxide Anion Production in Hypothalamic Paraventricular Nucleus Contribute to Capsaicin-Induced Excitatory Renal Reflex and Sympathetic Activation.

Authors:  Yun Qiu; Fen Zheng; Chao Ye; Ai-Dong Chen; Jue-Jin Wang; Qi Chen; Yue-Hua Li; Yu-Ming Kang; Guo-Qing Zhu
Journal:  Neurosci Bull       Date:  2020-01-27       Impact factor: 5.203

Review 3.  Modulation of Sympathetic Overactivity to Treat Resistant Hypertension.

Authors:  Raven Voora; Alan L Hinderliter
Journal:  Curr Hypertens Rep       Date:  2018-09-07       Impact factor: 5.369

Review 4.  Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?

Authors:  Hamish Cg Prosser; Cynthia Gregory; Dagmara Hering; Graham S Hillis; Greg Perry; Johan Rosman; Carl Schultz; Mark Thomas; Gerald F Watts; Markus P Schlaich
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

5.  Sympathetic function during whole body cooling is altered in hypertensive adults.

Authors:  Jody L Greaney; W Larry Kenney; Lacy M Alexander
Journal:  J Appl Physiol (1985)       Date:  2017-09-14

6.  Neurovascular mechanisms underlying augmented cold-induced reflex cutaneous vasoconstriction in human hypertension.

Authors:  Jody L Greaney; W Larry Kenney; Lacy M Alexander
Journal:  J Physiol       Date:  2017-01-16       Impact factor: 5.182

7.  Exercise-induced α-ketoglutaric acid stimulates muscle hypertrophy and fat loss through OXGR1-dependent adrenal activation.

Authors:  Yexian Yuan; Pingwen Xu; Qingyan Jiang; Gang Shu; Xingcai Cai; Tao Wang; Wentong Peng; Jiajie Sun; Canjun Zhu; Cha Zhang; Dong Yue; Zhihui He; Jinping Yang; Yuxian Zeng; Man Du; Fenglin Zhang; Lucas Ibrahimi; Sarah Schaul; Yuwei Jiang; Jiqiu Wang; Jia Sun; Qiaoping Wang; Liming Liu; Songbo Wang; Lina Wang; Xiaotong Zhu; Ping Gao; Qianyun Xi; Cong Yin; Fan Li; Guli Xu; Yongliang Zhang
Journal:  EMBO J       Date:  2020-02-27       Impact factor: 11.598

Review 8.  Genomics of Cardiovascular Measures of Autonomic Tone.

Authors:  Martin I Sigurdsson; Nathan H Waldron; Andrey V Bortsov; Shad B Smith; William Maixner
Journal:  J Cardiovasc Pharmacol       Date:  2018-03       Impact factor: 3.105

9.  Circulating miR-92a expression level in patients with essential hypertension: a potential marker of atherosclerosis.

Authors:  Y Huang; S Tang; C Ji-Yan; C Huang; J Li; A-P Cai; Y-Q Feng
Journal:  J Hum Hypertens       Date:  2016-09-15       Impact factor: 3.012

10.  A Global Perspective on Using Implementation Research to Address Hypertension-Associated Target Organ Damage.

Authors:  Emmanuel Peprah; Maria Lopez-Class; Susan Shero; Joylene John-Sowah; Michael Engelgau
Journal:  Ethn Dis       Date:  2016-07-21       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.